The healthcare sector scored gains amid benign economic indicators and despite discouraging news from some of its components.
Shares of Cooper Cos. fell 15% after the company narrowed its guidance on moderating sales.
Regeneron Pharmaceuticals stock slumped 19% after two late-stage trials for an experimental drug co-developed with Sanofi only partially met goals.
Write to Paulo Trevisani at paulo.trevisani@wsj.com
(END) Dow Jones Newswires
05-30-25 1732ET